Incannex Healthcare Ltd’s (ASX: IHL) subsidiary,Clarion Clinics Group is now accepting direct registration of interest from potential clients for its next phase psychedelic treatments for issues such as PTSD.
This is the first step in the process towards receiving treatment and we anticipate that there will be a high level of interest in our leading-edge treatments,” said Peter Widdows, Incannex Director responsible for Clarion.
“Clarion’s first clinic is located on the Yarra Riverfront in the Melbourne suburb of Abbotsford, close to the city centre. It’s a purpose-designed facility with seven treatment rooms and other facilities conducive to psychedelic-assisted therapy. The fit-out of the premises is expected to be completed before the end of August, facilitating opening shortly thereafter.
Sean O’Carroll, Clarion Director and Head of Psychotherapy, said a lot of thought went into the design of the clinic, as both practical and aesthetic considerations are very important for this type of treatment.
“It’s imperative that clients feel welcome, comfortable and safe. We wanted the design of the space to support a sense of calm and a positive mindset, as we know these things contribute to better treatment outcomes.”
Australian health authorities estimate that 12% of Australians will suffer from PTSD at some point in their lifetime, and 1.5% of the population (390,000 people) have a PTSD diagnosis at any given time. Certain groups, for example people who serve in the defence force, military veterans, first responders, and certain minority groups make up a disproportionate share of people who experience this debilitating mental health disorder.
Along with the many sufferers of PTSD, it’s estimated that 26.5% of the just over one million Australians who suffer depression (280,000 people) do not adequately respond to standard treatments.
“The term ‘treatment-resistant’ has misleading connotations, implying that all avenues have been exhausted and that front-line treatments work well for everyone else. In reality, neither are typically true. For people who have suffered with certain conditions that have not responded to available treatments, psychedelic-assisted therapies may provide substantial improvements to negative symptoms and quality of life. At Clarion Clinics, our aim is to achieve the best outcomes possible using psychedelic therapies, through tailored and extended protocols and a brilliant team,” Dr. Paul Liknaitzky said.
